Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upstream Targeting for the Prevention of Atrial Fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)

NCT03603912 is registered in ClinicalTrials.gov with Mina Chung, MD as lead sponsor.

NCT NCT03603912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03603912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upstream Targeting for the Prevention of Atrial Fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)
Lead sponsor
Mina Chung, MD
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 24, 2018
Completion date
December 31, 2027
Enrollment
175 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation